Global Plasma and Serum Proteomics Analysis Service Supply, Demand and Key Producers, 2026-2032
The global Plasma and Serum Proteomics Analysis Service market size is expected to reach $ 1651 million by 2032, rising at a market growth of 11.8% CAGR during the forecast period (2026-2032).
Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report studies the global Plasma and Serum Proteomics Analysis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Plasma and Serum Proteomics Analysis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Plasma and Serum Proteomics Analysis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Plasma and Serum Proteomics Analysis Service total market, 2021-2032, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Plasma and Serum Proteomics Analysis Service total market, key domestic companies, and share, (USD Million)
Global Plasma and Serum Proteomics Analysis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Plasma and Serum Proteomics Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Plasma and Serum Proteomics Analysis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Plasma and Serum Proteomics Analysis Service Market, By Region:
1. How big is the global Plasma and Serum Proteomics Analysis Service market?
2. What is the demand of the global Plasma and Serum Proteomics Analysis Service market?
3. What is the year over year growth of the global Plasma and Serum Proteomics Analysis Service market?
4. What is the total value of the global Plasma and Serum Proteomics Analysis Service market?
5. Who are the Major Players in the global Plasma and Serum Proteomics Analysis Service market?
6. What are the growth factors driving the market demand?
Plasma and Serum Proteomics Analysis Service refers to specialized research services that utilize plasma and serum samples as primary biological materials and apply advanced proteomics technologies to systematically identify, quantify, and interpret circulating proteins, protein expression patterns, functional alterations, and disease-associated molecular signatures.
As one of the most accessible liquid biological sample types, plasma and serum contain extensive molecular information released from multiple tissues, organs, and immune systems. Plasma and serum proteomics provides valuable insights into disease development, treatment response, and biological regulation. Compared with genomics and transcriptomics, proteomics is closer to the functional execution layer of biology because it directly measures proteins responsible for cellular activities.
Plasma and Serum Proteomics Analysis Service typically integrates high-resolution liquid chromatography tandem mass spectrometry (LC-MS/MS), data-independent acquisition (DIA), parallel reaction monitoring (PRM), tandem mass tag (TMT) labeling, proximity extension assay (PEA), and aptamer-based proteomics technologies. Combined with artificial intelligence, bioinformatics, and multi-omics analysis, these services provide complete workflows covering sample preparation, protein profiling, quantitative analysis, biomarker discovery, and pathway interpretation.
These services are widely applied in cancer screening, immuno-oncology, cardiovascular research, neurodegenerative diseases, autoimmune disorders, metabolic diseases, infectious diseases, and pharmaceutical development. Olink provides plasma and serum-based high-throughput protein analysis services through its Analysis Services platform, supporting biomarker studies ranging from focused research projects to large-scale population studies.
Plasma and Serum Proteomics Analysis Services primarily operate under a technology-intensive life science CRO model combining advanced analytical platforms, specialized scientific expertise, and bioinformatics capabilities.
Unlike conventional laboratory testing services, this field requires integrated capabilities in biological sample processing, protein detection, large-scale data analysis, and biological interpretation. Service providers typically establish high-resolution mass spectrometry platforms, automated sample preparation systems, multiplex protein detection platforms, and computational analysis infrastructures to deliver customized proteomics solutions.
The typical workflow includes study design, plasma/serum sample receiving and quality control, protein extraction, depletion of high-abundance proteins or enrichment of target proteins, enzymatic digestion, mass spectrometry or affinity-based detection, protein quantification, statistical modeling, biomarker discovery, pathway analysis, and final scientific reporting.
The industry value chain includes upstream suppliers of mass spectrometry instruments, chromatography systems, antibodies, reagents, aptamer technologies, laboratory consumables, and bioinformatics software. The midstream consists of proteomics CRO providers, multi-omics platforms, and clinical research service companies. Downstream customers include pharmaceutical companies, biotechnology firms, hospitals, biobanks, and precision medicine organizations.
Plasma and serum proteomics services represent a high-value-added segment. Standardized plasma profiling services generally achieve gross margins of approximately 40%-60%, while advanced DIA-MS, TMT-MS, deep proteomics, and clinical cohort projects may achieve margins of 55%-75% due to higher technological complexity and analytical value.
Plasma and Serum Proteomics Analysis Services are becoming essential technology platforms for precision medicine, innovative drug discovery, and clinical translation research.
As life science research moves from genomic information toward functional protein characterization, pharmaceutical companies and research institutions increasingly require circulating protein biomarkers, disease prediction models, and treatment response evaluation. Plasma and serum provide accessible, repeatable, and scalable sample sources, making them among the most commercially valuable sample types in proteomics.
The expansion of biobanks, AI-driven protein analytics, multi-omics integration, and companion diagnostic development continues to accelerate market growth. In oncology, immunotherapy, neurodegenerative diseases, and chronic disease management, plasma and serum proteomics can reveal molecular signals that are difficult to capture through conventional approaches, supporting target discovery and precision therapies. The combination of proteomics and artificial intelligence is further improving biological data interpretation capabilities.
The market faces challenges including high technical complexity, difficulty detecting low-abundance proteins, limited standardization, and lengthy clinical validation processes.
Blood samples contain highly abundant proteins that may interfere with the detection of disease-related biomarkers. Therefore, advanced enrichment strategies, deep mass spectrometry, and highly sensitive analytical technologies are required. Data consistency between platforms, standardized workflows, and regulatory requirements will influence future commercialization.
Future demand for Plasma and Serum Proteomics Analysis Services will increasingly focus on pharmaceutical development, clinical research, and large-scale population studies.
Pharmaceutical companies will utilize plasma and serum proteomics for target discovery, mechanism-of-action studies, patient stratification, and clinical trial optimization. Biotechnology companies will increasingly rely on specialized CRO providers to reduce infrastructure investment and accelerate innovation. Research institutions and hospitals will expand applications in oncology, cardiovascular disease, neurological disorders, and immune-related diseases.
With the continued development of precision medicine and data-driven biology, service providers with high-throughput platforms, advanced analytics, proprietary databases, and global delivery capabilities will become increasingly valuable partners across the life science ecosystem.
Report Scope
This report studies the global Plasma and Serum Proteomics Analysis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Plasma and Serum Proteomics Analysis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Plasma and Serum Proteomics Analysis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Plasma and Serum Proteomics Analysis Service total market, 2021-2032, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Plasma and Serum Proteomics Analysis Service total market, key domestic companies, and share, (USD Million)
Global Plasma and Serum Proteomics Analysis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Plasma and Serum Proteomics Analysis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Plasma and Serum Proteomics Analysis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Olink (Thermo Fisher Scientific), SomaLogic (Illumina), Labcorp, BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Plasma and Serum Proteomics Analysis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Plasma and Serum Proteomics Analysis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Plasma Proteomics Analysis Service
- Serum Proteomics Analysis Service
- Universities and Research Institutes
- Hospitals
- Pharmaceutical Companies
- Others
- Oncology
- Cardiovascular
- Agriculture
- Neuroscience
- Other
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
1. How big is the global Plasma and Serum Proteomics Analysis Service market?
2. What is the demand of the global Plasma and Serum Proteomics Analysis Service market?
3. What is the year over year growth of the global Plasma and Serum Proteomics Analysis Service market?
4. What is the total value of the global Plasma and Serum Proteomics Analysis Service market?
5. Who are the Major Players in the global Plasma and Serum Proteomics Analysis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Plasma and Serum Proteomics Analysis Service Introduction
1.2 World Plasma and Serum Proteomics Analysis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Plasma and Serum Proteomics Analysis Service Total Market by Region (by Headquarter Location)
1.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.3 China Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.4 Europe Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.5 Japan Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.8 India Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Plasma and Serum Proteomics Analysis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.2 World Plasma and Serum Proteomics Analysis Service Consumption Value by Region
2.2.1 World Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026)
2.2.2 World Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.4 China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.5 Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.6 Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.7 South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.8 ASEAN Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.9 India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
3 WORLD PLASMA AND SERUM PROTEOMICS ANALYSIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Plasma and Serum Proteomics Analysis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Plasma and Serum Proteomics Analysis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Plasma and Serum Proteomics Analysis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Plasma and Serum Proteomics Analysis Service in 2025
3.3 Plasma and Serum Proteomics Analysis Service Company Evaluation Quadrant
3.4 Plasma and Serum Proteomics Analysis Service Market: Overall Company Footprint Analysis
3.4.1 Plasma and Serum Proteomics Analysis Service Market: Region Footprint
3.4.2 Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
3.4.3 Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Plasma and Serum Proteomics Analysis Service Consumption Value Comparison
4.2.1 United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Plasma and Serum Proteomics Analysis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026)
4.4 China Based Companies Plasma and Serum Proteomics Analysis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Plasma and Serum Proteomics Analysis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026)
4.5 Rest of World Based Plasma and Serum Proteomics Analysis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plasma Proteomics Analysis Service
5.2.2 Serum Proteomics Analysis Service
5.3 Market Segment by Type
5.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)
5.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Type (2027-2032)
5.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Universities and Research Institutes
6.2.2 Hospitals
6.2.3 Pharmaceutical Companies
6.2.4 Others
6.3 Market Segment by End User
6.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by End User (2021-2026)
6.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by End User (2027-2032)
6.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY RESEARCH AREAS
7.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Research Areas: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Areas
7.2.1 Oncology
7.2.2 Cardiovascular
7.2.3 Agriculture
7.2.4 Neuroscience
7.2.5 Other
7.3 Market Segment by Research Areas
7.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2021-2026)
7.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2027-2032)
7.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Research
8.2.2 Drug Development
8.2.3 Clinical Research
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)
8.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Application (2027-2032)
8.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Olink (Thermo Fisher Scientific)
9.1.1 Olink (Thermo Fisher Scientific) Details
9.1.2 Olink (Thermo Fisher Scientific) Major Business
9.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Services
9.1.4 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Olink (Thermo Fisher Scientific) Recent Developments/Updates
9.1.6 Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
9.2 SomaLogic (Illumina)
9.2.1 SomaLogic (Illumina) Details
9.2.2 SomaLogic (Illumina) Major Business
9.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Services
9.2.4 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SomaLogic (Illumina) Recent Developments/Updates
9.2.6 SomaLogic (Illumina) Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Product and Services
9.3.4 Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 BostonGene
9.4.1 BostonGene Details
9.4.2 BostonGene Major Business
9.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Product and Services
9.4.4 BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BostonGene Recent Developments/Updates
9.4.6 BostonGene Competitive Strengths & Weaknesses
9.5 CellCarta
9.5.1 CellCarta Details
9.5.2 CellCarta Major Business
9.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Product and Services
9.5.4 CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CellCarta Recent Developments/Updates
9.5.6 CellCarta Competitive Strengths & Weaknesses
9.6 GENEWIZ (Azenta Life Sciences)
9.6.1 GENEWIZ (Azenta Life Sciences) Details
9.6.2 GENEWIZ (Azenta Life Sciences) Major Business
9.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Services
9.6.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
9.6.6 GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
9.7 CDI Labs
9.7.1 CDI Labs Details
9.7.2 CDI Labs Major Business
9.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Product and Services
9.7.4 CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CDI Labs Recent Developments/Updates
9.7.6 CDI Labs Competitive Strengths & Weaknesses
9.8 Biognosys
9.8.1 Biognosys Details
9.8.2 Biognosys Major Business
9.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Product and Services
9.8.4 Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Biognosys Recent Developments/Updates
9.8.6 Biognosys Competitive Strengths & Weaknesses
9.9 Discovery Life Sciences
9.9.1 Discovery Life Sciences Details
9.9.2 Discovery Life Sciences Major Business
9.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Services
9.9.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Discovery Life Sciences Recent Developments/Updates
9.9.6 Discovery Life Sciences Competitive Strengths & Weaknesses
9.10 Firalis Molecular Precision
9.10.1 Firalis Molecular Precision Details
9.10.2 Firalis Molecular Precision Major Business
9.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Services
9.10.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Firalis Molecular Precision Recent Developments/Updates
9.10.6 Firalis Molecular Precision Competitive Strengths & Weaknesses
9.11 Cell Signaling Technology (CST)
9.11.1 Cell Signaling Technology (CST) Details
9.11.2 Cell Signaling Technology (CST) Major Business
9.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Services
9.11.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cell Signaling Technology (CST) Recent Developments/Updates
9.11.6 Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
9.12 Sampled (Infinity Biologix)
9.12.1 Sampled (Infinity Biologix) Details
9.12.2 Sampled (Infinity Biologix) Major Business
9.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Services
9.12.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sampled (Infinity Biologix) Recent Developments/Updates
9.12.6 Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
9.13 APTBIO
9.13.1 APTBIO Details
9.13.2 APTBIO Major Business
9.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Product and Services
9.13.4 APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 APTBIO Recent Developments/Updates
9.13.6 APTBIO Competitive Strengths & Weaknesses
9.14 Sinotech Genomics
9.14.1 Sinotech Genomics Details
9.14.2 Sinotech Genomics Major Business
9.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Services
9.14.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sinotech Genomics Recent Developments/Updates
9.14.6 Sinotech Genomics Competitive Strengths & Weaknesses
9.15 Biodesix
9.15.1 Biodesix Details
9.15.2 Biodesix Major Business
9.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Product and Services
9.15.4 Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biodesix Recent Developments/Updates
9.15.6 Biodesix Competitive Strengths & Weaknesses
9.16 Panome Bio
9.16.1 Panome Bio Details
9.16.2 Panome Bio Major Business
9.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Product and Services
9.16.4 Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Panome Bio Recent Developments/Updates
9.16.6 Panome Bio Competitive Strengths & Weaknesses
9.17 Novogene
9.17.1 Novogene Details
9.17.2 Novogene Major Business
9.17.3 Novogene Plasma and Serum Proteomics Analysis Service Product and Services
9.17.4 Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Novogene Recent Developments/Updates
9.17.6 Novogene Competitive Strengths & Weaknesses
9.18 PTM BIO
9.18.1 PTM BIO Details
9.18.2 PTM BIO Major Business
9.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Product and Services
9.18.4 PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PTM BIO Recent Developments/Updates
9.18.6 PTM BIO Competitive Strengths & Weaknesses
9.19 BGI Genomics
9.19.1 BGI Genomics Details
9.19.2 BGI Genomics Major Business
9.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Services
9.19.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 BGI Genomics Recent Developments/Updates
9.19.6 BGI Genomics Competitive Strengths & Weaknesses
9.20 Evotec
9.20.1 Evotec Details
9.20.2 Evotec Major Business
9.20.3 Evotec Plasma and Serum Proteomics Analysis Service Product and Services
9.20.4 Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Evotec Recent Developments/Updates
9.20.6 Evotec Competitive Strengths & Weaknesses
9.21 Metware Biotechnology
9.21.1 Metware Biotechnology Details
9.21.2 Metware Biotechnology Major Business
9.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Services
9.21.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Metware Biotechnology Recent Developments/Updates
9.21.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.22 MRM Proteomics
9.22.1 MRM Proteomics Details
9.22.2 MRM Proteomics Major Business
9.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.22.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 MRM Proteomics Recent Developments/Updates
9.22.6 MRM Proteomics Competitive Strengths & Weaknesses
9.23 Lc-Bio Technologies
9.23.1 Lc-Bio Technologies Details
9.23.2 Lc-Bio Technologies Major Business
9.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Services
9.23.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lc-Bio Technologies Recent Developments/Updates
9.23.6 Lc-Bio Technologies Competitive Strengths & Weaknesses
9.24 Eurofins Scientific
9.24.1 Eurofins Scientific Details
9.24.2 Eurofins Scientific Major Business
9.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Services
9.24.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Eurofins Scientific Recent Developments/Updates
9.24.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.25 MtoZ-Biolabs
9.25.1 MtoZ-Biolabs Details
9.25.2 MtoZ-Biolabs Major Business
9.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Services
9.25.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MtoZ-Biolabs Recent Developments/Updates
9.25.6 MtoZ-Biolabs Competitive Strengths & Weaknesses
9.26 Creative Proteomics
9.26.1 Creative Proteomics Details
9.26.2 Creative Proteomics Major Business
9.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.26.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Creative Proteomics Recent Developments/Updates
9.26.6 Creative Proteomics Competitive Strengths & Weaknesses
9.27 Macrogen
9.27.1 Macrogen Details
9.27.2 Macrogen Major Business
9.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Product and Services
9.27.4 Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Macrogen Recent Developments/Updates
9.27.6 Macrogen Competitive Strengths & Weaknesses
9.28 TATAA Biocenter
9.28.1 TATAA Biocenter Details
9.28.2 TATAA Biocenter Major Business
9.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Services
9.28.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 TATAA Biocenter Recent Developments/Updates
9.28.6 TATAA Biocenter Competitive Strengths & Weaknesses
9.29 OmicScouts (Momentum Biotechnologies)
9.29.1 OmicScouts (Momentum Biotechnologies) Details
9.29.2 OmicScouts (Momentum Biotechnologies) Major Business
9.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Services
9.29.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
9.29.6 OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
9.30 Precision Biomarker Laboratories (PBL)
9.30.1 Precision Biomarker Laboratories (PBL) Details
9.30.2 Precision Biomarker Laboratories (PBL) Major Business
9.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Services
9.30.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Precision Biomarker Laboratories (PBL) Recent Developments/Updates
9.30.6 Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
9.31 Shanghai OE Biotech
9.31.1 Shanghai OE Biotech Details
9.31.2 Shanghai OE Biotech Major Business
9.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Services
9.31.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Shanghai OE Biotech Recent Developments/Updates
9.31.6 Shanghai OE Biotech Competitive Strengths & Weaknesses
9.32 RxCelerate
9.32.1 RxCelerate Details
9.32.2 RxCelerate Major Business
9.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Product and Services
9.32.4 RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 RxCelerate Recent Developments/Updates
9.32.6 RxCelerate Competitive Strengths & Weaknesses
9.33 Proteomics International
9.33.1 Proteomics International Details
9.33.2 Proteomics International Major Business
9.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Product and Services
9.33.4 Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Proteomics International Recent Developments/Updates
9.33.6 Proteomics International Competitive Strengths & Weaknesses
9.34 Proteome Sciences
9.34.1 Proteome Sciences Details
9.34.2 Proteome Sciences Major Business
9.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Services
9.34.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Proteome Sciences Recent Developments/Updates
9.34.6 Proteome Sciences Competitive Strengths & Weaknesses
9.35 Westlake Omics
9.35.1 Westlake Omics Details
9.35.2 Westlake Omics Major Business
9.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Services
9.35.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Westlake Omics Recent Developments/Updates
9.35.6 Westlake Omics Competitive Strengths & Weaknesses
9.36 Crown Bioscience
9.36.1 Crown Bioscience Details
9.36.2 Crown Bioscience Major Business
9.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Services
9.36.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Crown Bioscience Recent Developments/Updates
9.36.6 Crown Bioscience Competitive Strengths & Weaknesses
9.37 VProteomics
9.37.1 VProteomics Details
9.37.2 VProteomics Major Business
9.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.37.4 VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 VProteomics Recent Developments/Updates
9.37.6 VProteomics Competitive Strengths & Weaknesses
9.38 Shanghai Majorbio Bio-Pharm
9.38.1 Shanghai Majorbio Bio-Pharm Details
9.38.2 Shanghai Majorbio Bio-Pharm Major Business
9.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Services
9.38.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Shanghai Majorbio Bio-Pharm Recent Developments/Updates
9.38.6 Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
9.39 Applied Biomics
9.39.1 Applied Biomics Details
9.39.2 Applied Biomics Major Business
9.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Services
9.39.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Applied Biomics Recent Developments/Updates
9.39.6 Applied Biomics Competitive Strengths & Weaknesses
9.40 Sapient Bioanalytics
9.40.1 Sapient Bioanalytics Details
9.40.2 Sapient Bioanalytics Major Business
9.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Services
9.40.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.40.5 Sapient Bioanalytics Recent Developments/Updates
9.40.6 Sapient Bioanalytics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Plasma and Serum Proteomics Analysis Service Industry Chain
10.2 Plasma and Serum Proteomics Analysis Service Upstream Analysis
10.3 Plasma and Serum Proteomics Analysis Service Midstream Analysis
10.4 Plasma and Serum Proteomics Analysis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Plasma and Serum Proteomics Analysis Service Introduction
1.2 World Plasma and Serum Proteomics Analysis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Plasma and Serum Proteomics Analysis Service Total Market by Region (by Headquarter Location)
1.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.3 China Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.4 Europe Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.5 Japan Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.3.8 India Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Plasma and Serum Proteomics Analysis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.2 World Plasma and Serum Proteomics Analysis Service Consumption Value by Region
2.2.1 World Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026)
2.2.2 World Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.4 China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.5 Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.6 Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.7 South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.8 ASEAN Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
2.9 India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032)
3 WORLD PLASMA AND SERUM PROTEOMICS ANALYSIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Plasma and Serum Proteomics Analysis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Plasma and Serum Proteomics Analysis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Plasma and Serum Proteomics Analysis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Plasma and Serum Proteomics Analysis Service in 2025
3.3 Plasma and Serum Proteomics Analysis Service Company Evaluation Quadrant
3.4 Plasma and Serum Proteomics Analysis Service Market: Overall Company Footprint Analysis
3.4.1 Plasma and Serum Proteomics Analysis Service Market: Region Footprint
3.4.2 Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
3.4.3 Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Plasma and Serum Proteomics Analysis Service Consumption Value Comparison
4.2.1 United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Plasma and Serum Proteomics Analysis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026)
4.4 China Based Companies Plasma and Serum Proteomics Analysis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Plasma and Serum Proteomics Analysis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026)
4.5 Rest of World Based Plasma and Serum Proteomics Analysis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plasma Proteomics Analysis Service
5.2.2 Serum Proteomics Analysis Service
5.3 Market Segment by Type
5.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Type (2021-2026)
5.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Type (2027-2032)
5.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 Universities and Research Institutes
6.2.2 Hospitals
6.2.3 Pharmaceutical Companies
6.2.4 Others
6.3 Market Segment by End User
6.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by End User (2021-2026)
6.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by End User (2027-2032)
6.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User (2027-2032)
7 MARKET ANALYSIS BY RESEARCH AREAS
7.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Research Areas: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Areas
7.2.1 Oncology
7.2.2 Cardiovascular
7.2.3 Agriculture
7.2.4 Neuroscience
7.2.5 Other
7.3 Market Segment by Research Areas
7.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2021-2026)
7.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2027-2032)
7.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Plasma and Serum Proteomics Analysis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Research
8.2.2 Drug Development
8.2.3 Clinical Research
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026)
8.3.2 World Plasma and Serum Proteomics Analysis Service Market Size by Application (2027-2032)
8.3.3 World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Olink (Thermo Fisher Scientific)
9.1.1 Olink (Thermo Fisher Scientific) Details
9.1.2 Olink (Thermo Fisher Scientific) Major Business
9.1.3 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Services
9.1.4 Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Olink (Thermo Fisher Scientific) Recent Developments/Updates
9.1.6 Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
9.2 SomaLogic (Illumina)
9.2.1 SomaLogic (Illumina) Details
9.2.2 SomaLogic (Illumina) Major Business
9.2.3 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Services
9.2.4 SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 SomaLogic (Illumina) Recent Developments/Updates
9.2.6 SomaLogic (Illumina) Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Plasma and Serum Proteomics Analysis Service Product and Services
9.3.4 Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 BostonGene
9.4.1 BostonGene Details
9.4.2 BostonGene Major Business
9.4.3 BostonGene Plasma and Serum Proteomics Analysis Service Product and Services
9.4.4 BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 BostonGene Recent Developments/Updates
9.4.6 BostonGene Competitive Strengths & Weaknesses
9.5 CellCarta
9.5.1 CellCarta Details
9.5.2 CellCarta Major Business
9.5.3 CellCarta Plasma and Serum Proteomics Analysis Service Product and Services
9.5.4 CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 CellCarta Recent Developments/Updates
9.5.6 CellCarta Competitive Strengths & Weaknesses
9.6 GENEWIZ (Azenta Life Sciences)
9.6.1 GENEWIZ (Azenta Life Sciences) Details
9.6.2 GENEWIZ (Azenta Life Sciences) Major Business
9.6.3 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Services
9.6.4 GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
9.6.6 GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
9.7 CDI Labs
9.7.1 CDI Labs Details
9.7.2 CDI Labs Major Business
9.7.3 CDI Labs Plasma and Serum Proteomics Analysis Service Product and Services
9.7.4 CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CDI Labs Recent Developments/Updates
9.7.6 CDI Labs Competitive Strengths & Weaknesses
9.8 Biognosys
9.8.1 Biognosys Details
9.8.2 Biognosys Major Business
9.8.3 Biognosys Plasma and Serum Proteomics Analysis Service Product and Services
9.8.4 Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Biognosys Recent Developments/Updates
9.8.6 Biognosys Competitive Strengths & Weaknesses
9.9 Discovery Life Sciences
9.9.1 Discovery Life Sciences Details
9.9.2 Discovery Life Sciences Major Business
9.9.3 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Services
9.9.4 Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Discovery Life Sciences Recent Developments/Updates
9.9.6 Discovery Life Sciences Competitive Strengths & Weaknesses
9.10 Firalis Molecular Precision
9.10.1 Firalis Molecular Precision Details
9.10.2 Firalis Molecular Precision Major Business
9.10.3 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Services
9.10.4 Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Firalis Molecular Precision Recent Developments/Updates
9.10.6 Firalis Molecular Precision Competitive Strengths & Weaknesses
9.11 Cell Signaling Technology (CST)
9.11.1 Cell Signaling Technology (CST) Details
9.11.2 Cell Signaling Technology (CST) Major Business
9.11.3 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Services
9.11.4 Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Cell Signaling Technology (CST) Recent Developments/Updates
9.11.6 Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
9.12 Sampled (Infinity Biologix)
9.12.1 Sampled (Infinity Biologix) Details
9.12.2 Sampled (Infinity Biologix) Major Business
9.12.3 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Services
9.12.4 Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sampled (Infinity Biologix) Recent Developments/Updates
9.12.6 Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
9.13 APTBIO
9.13.1 APTBIO Details
9.13.2 APTBIO Major Business
9.13.3 APTBIO Plasma and Serum Proteomics Analysis Service Product and Services
9.13.4 APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 APTBIO Recent Developments/Updates
9.13.6 APTBIO Competitive Strengths & Weaknesses
9.14 Sinotech Genomics
9.14.1 Sinotech Genomics Details
9.14.2 Sinotech Genomics Major Business
9.14.3 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Services
9.14.4 Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sinotech Genomics Recent Developments/Updates
9.14.6 Sinotech Genomics Competitive Strengths & Weaknesses
9.15 Biodesix
9.15.1 Biodesix Details
9.15.2 Biodesix Major Business
9.15.3 Biodesix Plasma and Serum Proteomics Analysis Service Product and Services
9.15.4 Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Biodesix Recent Developments/Updates
9.15.6 Biodesix Competitive Strengths & Weaknesses
9.16 Panome Bio
9.16.1 Panome Bio Details
9.16.2 Panome Bio Major Business
9.16.3 Panome Bio Plasma and Serum Proteomics Analysis Service Product and Services
9.16.4 Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Panome Bio Recent Developments/Updates
9.16.6 Panome Bio Competitive Strengths & Weaknesses
9.17 Novogene
9.17.1 Novogene Details
9.17.2 Novogene Major Business
9.17.3 Novogene Plasma and Serum Proteomics Analysis Service Product and Services
9.17.4 Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Novogene Recent Developments/Updates
9.17.6 Novogene Competitive Strengths & Weaknesses
9.18 PTM BIO
9.18.1 PTM BIO Details
9.18.2 PTM BIO Major Business
9.18.3 PTM BIO Plasma and Serum Proteomics Analysis Service Product and Services
9.18.4 PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 PTM BIO Recent Developments/Updates
9.18.6 PTM BIO Competitive Strengths & Weaknesses
9.19 BGI Genomics
9.19.1 BGI Genomics Details
9.19.2 BGI Genomics Major Business
9.19.3 BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Services
9.19.4 BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 BGI Genomics Recent Developments/Updates
9.19.6 BGI Genomics Competitive Strengths & Weaknesses
9.20 Evotec
9.20.1 Evotec Details
9.20.2 Evotec Major Business
9.20.3 Evotec Plasma and Serum Proteomics Analysis Service Product and Services
9.20.4 Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Evotec Recent Developments/Updates
9.20.6 Evotec Competitive Strengths & Weaknesses
9.21 Metware Biotechnology
9.21.1 Metware Biotechnology Details
9.21.2 Metware Biotechnology Major Business
9.21.3 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Services
9.21.4 Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Metware Biotechnology Recent Developments/Updates
9.21.6 Metware Biotechnology Competitive Strengths & Weaknesses
9.22 MRM Proteomics
9.22.1 MRM Proteomics Details
9.22.2 MRM Proteomics Major Business
9.22.3 MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.22.4 MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 MRM Proteomics Recent Developments/Updates
9.22.6 MRM Proteomics Competitive Strengths & Weaknesses
9.23 Lc-Bio Technologies
9.23.1 Lc-Bio Technologies Details
9.23.2 Lc-Bio Technologies Major Business
9.23.3 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Services
9.23.4 Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lc-Bio Technologies Recent Developments/Updates
9.23.6 Lc-Bio Technologies Competitive Strengths & Weaknesses
9.24 Eurofins Scientific
9.24.1 Eurofins Scientific Details
9.24.2 Eurofins Scientific Major Business
9.24.3 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Services
9.24.4 Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Eurofins Scientific Recent Developments/Updates
9.24.6 Eurofins Scientific Competitive Strengths & Weaknesses
9.25 MtoZ-Biolabs
9.25.1 MtoZ-Biolabs Details
9.25.2 MtoZ-Biolabs Major Business
9.25.3 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Services
9.25.4 MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 MtoZ-Biolabs Recent Developments/Updates
9.25.6 MtoZ-Biolabs Competitive Strengths & Weaknesses
9.26 Creative Proteomics
9.26.1 Creative Proteomics Details
9.26.2 Creative Proteomics Major Business
9.26.3 Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.26.4 Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 Creative Proteomics Recent Developments/Updates
9.26.6 Creative Proteomics Competitive Strengths & Weaknesses
9.27 Macrogen
9.27.1 Macrogen Details
9.27.2 Macrogen Major Business
9.27.3 Macrogen Plasma and Serum Proteomics Analysis Service Product and Services
9.27.4 Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Macrogen Recent Developments/Updates
9.27.6 Macrogen Competitive Strengths & Weaknesses
9.28 TATAA Biocenter
9.28.1 TATAA Biocenter Details
9.28.2 TATAA Biocenter Major Business
9.28.3 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Services
9.28.4 TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 TATAA Biocenter Recent Developments/Updates
9.28.6 TATAA Biocenter Competitive Strengths & Weaknesses
9.29 OmicScouts (Momentum Biotechnologies)
9.29.1 OmicScouts (Momentum Biotechnologies) Details
9.29.2 OmicScouts (Momentum Biotechnologies) Major Business
9.29.3 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Services
9.29.4 OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
9.29.6 OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
9.30 Precision Biomarker Laboratories (PBL)
9.30.1 Precision Biomarker Laboratories (PBL) Details
9.30.2 Precision Biomarker Laboratories (PBL) Major Business
9.30.3 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Services
9.30.4 Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Precision Biomarker Laboratories (PBL) Recent Developments/Updates
9.30.6 Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
9.31 Shanghai OE Biotech
9.31.1 Shanghai OE Biotech Details
9.31.2 Shanghai OE Biotech Major Business
9.31.3 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Services
9.31.4 Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Shanghai OE Biotech Recent Developments/Updates
9.31.6 Shanghai OE Biotech Competitive Strengths & Weaknesses
9.32 RxCelerate
9.32.1 RxCelerate Details
9.32.2 RxCelerate Major Business
9.32.3 RxCelerate Plasma and Serum Proteomics Analysis Service Product and Services
9.32.4 RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 RxCelerate Recent Developments/Updates
9.32.6 RxCelerate Competitive Strengths & Weaknesses
9.33 Proteomics International
9.33.1 Proteomics International Details
9.33.2 Proteomics International Major Business
9.33.3 Proteomics International Plasma and Serum Proteomics Analysis Service Product and Services
9.33.4 Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Proteomics International Recent Developments/Updates
9.33.6 Proteomics International Competitive Strengths & Weaknesses
9.34 Proteome Sciences
9.34.1 Proteome Sciences Details
9.34.2 Proteome Sciences Major Business
9.34.3 Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Services
9.34.4 Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Proteome Sciences Recent Developments/Updates
9.34.6 Proteome Sciences Competitive Strengths & Weaknesses
9.35 Westlake Omics
9.35.1 Westlake Omics Details
9.35.2 Westlake Omics Major Business
9.35.3 Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Services
9.35.4 Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Westlake Omics Recent Developments/Updates
9.35.6 Westlake Omics Competitive Strengths & Weaknesses
9.36 Crown Bioscience
9.36.1 Crown Bioscience Details
9.36.2 Crown Bioscience Major Business
9.36.3 Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Services
9.36.4 Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Crown Bioscience Recent Developments/Updates
9.36.6 Crown Bioscience Competitive Strengths & Weaknesses
9.37 VProteomics
9.37.1 VProteomics Details
9.37.2 VProteomics Major Business
9.37.3 VProteomics Plasma and Serum Proteomics Analysis Service Product and Services
9.37.4 VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 VProteomics Recent Developments/Updates
9.37.6 VProteomics Competitive Strengths & Weaknesses
9.38 Shanghai Majorbio Bio-Pharm
9.38.1 Shanghai Majorbio Bio-Pharm Details
9.38.2 Shanghai Majorbio Bio-Pharm Major Business
9.38.3 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Services
9.38.4 Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Shanghai Majorbio Bio-Pharm Recent Developments/Updates
9.38.6 Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
9.39 Applied Biomics
9.39.1 Applied Biomics Details
9.39.2 Applied Biomics Major Business
9.39.3 Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Services
9.39.4 Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Applied Biomics Recent Developments/Updates
9.39.6 Applied Biomics Competitive Strengths & Weaknesses
9.40 Sapient Bioanalytics
9.40.1 Sapient Bioanalytics Details
9.40.2 Sapient Bioanalytics Major Business
9.40.3 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Services
9.40.4 Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026)
9.40.5 Sapient Bioanalytics Recent Developments/Updates
9.40.6 Sapient Bioanalytics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Plasma and Serum Proteomics Analysis Service Industry Chain
10.2 Plasma and Serum Proteomics Analysis Service Upstream Analysis
10.3 Plasma and Serum Proteomics Analysis Service Midstream Analysis
10.4 Plasma and Serum Proteomics Analysis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Plasma and Serum Proteomics Analysis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Plasma and Serum Proteomics Analysis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Plasma and Serum Proteomics Analysis Service Players in 2025
Table 12. World Plasma and Serum Proteomics Analysis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Plasma and Serum Proteomics Analysis Service Company Evaluation Quadrant
Table 14. Head Office of Key Plasma and Serum Proteomics Analysis Service Players
Table 15. Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
Table 16. Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
Table 17. Plasma and Serum Proteomics Analysis Service Mergers & Acquisitions Activity
Table 18. United States VS China Plasma and Serum Proteomics Analysis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Plasma and Serum Proteomics Analysis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 23. China Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 29. World Plasma and Serum Proteomics Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Plasma and Serum Proteomics Analysis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Plasma and Serum Proteomics Analysis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Plasma and Serum Proteomics Analysis Service Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Plasma and Serum Proteomics Analysis Service Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Plasma and Serum Proteomics Analysis Service Market Size by End User (2027-2032) & (USD Million)
Table 35. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 36. World Plasma and Serum Proteomics Analysis Service Market Size Value by Research Areas (2021-2026) & (USD Million)
Table 37. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2027-2032) & (USD Million)
Table 38. World Plasma and Serum Proteomics Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Plasma and Serum Proteomics Analysis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Olink (Thermo Fisher Scientific) Basic Information, Manufacturing Base and Competitors
Table 42. Olink (Thermo Fisher Scientific) Major Business
Table 43. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Services
Table 44. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Olink (Thermo Fisher Scientific) Recent Developments/Updates
Table 46. Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 47. SomaLogic (Illumina) Basic Information, Manufacturing Base and Competitors
Table 48. SomaLogic (Illumina) Major Business
Table 49. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Services
Table 50. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SomaLogic (Illumina) Recent Developments/Updates
Table 52. SomaLogic (Illumina) Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Plasma and Serum Proteomics Analysis Service Product and Services
Table 56. Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. BostonGene Basic Information, Manufacturing Base and Competitors
Table 60. BostonGene Major Business
Table 61. BostonGene Plasma and Serum Proteomics Analysis Service Product and Services
Table 62. BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BostonGene Recent Developments/Updates
Table 64. BostonGene Competitive Strengths & Weaknesses
Table 65. CellCarta Basic Information, Manufacturing Base and Competitors
Table 66. CellCarta Major Business
Table 67. CellCarta Plasma and Serum Proteomics Analysis Service Product and Services
Table 68. CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CellCarta Recent Developments/Updates
Table 70. CellCarta Competitive Strengths & Weaknesses
Table 71. GENEWIZ (Azenta Life Sciences) Basic Information, Manufacturing Base and Competitors
Table 72. GENEWIZ (Azenta Life Sciences) Major Business
Table 73. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Services
Table 74. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
Table 76. GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
Table 77. CDI Labs Basic Information, Manufacturing Base and Competitors
Table 78. CDI Labs Major Business
Table 79. CDI Labs Plasma and Serum Proteomics Analysis Service Product and Services
Table 80. CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CDI Labs Recent Developments/Updates
Table 82. CDI Labs Competitive Strengths & Weaknesses
Table 83. Biognosys Basic Information, Manufacturing Base and Competitors
Table 84. Biognosys Major Business
Table 85. Biognosys Plasma and Serum Proteomics Analysis Service Product and Services
Table 86. Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Biognosys Recent Developments/Updates
Table 88. Biognosys Competitive Strengths & Weaknesses
Table 89. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 90. Discovery Life Sciences Major Business
Table 91. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Services
Table 92. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Discovery Life Sciences Recent Developments/Updates
Table 94. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 95. Firalis Molecular Precision Basic Information, Manufacturing Base and Competitors
Table 96. Firalis Molecular Precision Major Business
Table 97. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Services
Table 98. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Firalis Molecular Precision Recent Developments/Updates
Table 100. Firalis Molecular Precision Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology (CST) Basic Information, Manufacturing Base and Competitors
Table 102. Cell Signaling Technology (CST) Major Business
Table 103. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Services
Table 104. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cell Signaling Technology (CST) Recent Developments/Updates
Table 106. Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
Table 107. Sampled (Infinity Biologix) Basic Information, Manufacturing Base and Competitors
Table 108. Sampled (Infinity Biologix) Major Business
Table 109. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Services
Table 110. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sampled (Infinity Biologix) Recent Developments/Updates
Table 112. Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
Table 113. APTBIO Basic Information, Manufacturing Base and Competitors
Table 114. APTBIO Major Business
Table 115. APTBIO Plasma and Serum Proteomics Analysis Service Product and Services
Table 116. APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. APTBIO Recent Developments/Updates
Table 118. APTBIO Competitive Strengths & Weaknesses
Table 119. Sinotech Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Sinotech Genomics Major Business
Table 121. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 122. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sinotech Genomics Recent Developments/Updates
Table 124. Sinotech Genomics Competitive Strengths & Weaknesses
Table 125. Biodesix Basic Information, Manufacturing Base and Competitors
Table 126. Biodesix Major Business
Table 127. Biodesix Plasma and Serum Proteomics Analysis Service Product and Services
Table 128. Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biodesix Recent Developments/Updates
Table 130. Biodesix Competitive Strengths & Weaknesses
Table 131. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 132. Panome Bio Major Business
Table 133. Panome Bio Plasma and Serum Proteomics Analysis Service Product and Services
Table 134. Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Panome Bio Recent Developments/Updates
Table 136. Panome Bio Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Manufacturing Base and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Plasma and Serum Proteomics Analysis Service Product and Services
Table 140. Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. PTM BIO Basic Information, Manufacturing Base and Competitors
Table 144. PTM BIO Major Business
Table 145. PTM BIO Plasma and Serum Proteomics Analysis Service Product and Services
Table 146. PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PTM BIO Recent Developments/Updates
Table 148. PTM BIO Competitive Strengths & Weaknesses
Table 149. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 150. BGI Genomics Major Business
Table 151. BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 152. BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. BGI Genomics Recent Developments/Updates
Table 154. BGI Genomics Competitive Strengths & Weaknesses
Table 155. Evotec Basic Information, Manufacturing Base and Competitors
Table 156. Evotec Major Business
Table 157. Evotec Plasma and Serum Proteomics Analysis Service Product and Services
Table 158. Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Evotec Recent Developments/Updates
Table 160. Evotec Competitive Strengths & Weaknesses
Table 161. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Metware Biotechnology Major Business
Table 163. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Services
Table 164. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Metware Biotechnology Recent Developments/Updates
Table 166. Metware Biotechnology Competitive Strengths & Weaknesses
Table 167. MRM Proteomics Basic Information, Manufacturing Base and Competitors
Table 168. MRM Proteomics Major Business
Table 169. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 170. MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. MRM Proteomics Recent Developments/Updates
Table 172. MRM Proteomics Competitive Strengths & Weaknesses
Table 173. Lc-Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 174. Lc-Bio Technologies Major Business
Table 175. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Services
Table 176. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lc-Bio Technologies Recent Developments/Updates
Table 178. Lc-Bio Technologies Competitive Strengths & Weaknesses
Table 179. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 180. Eurofins Scientific Major Business
Table 181. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Services
Table 182. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Eurofins Scientific Recent Developments/Updates
Table 184. Eurofins Scientific Competitive Strengths & Weaknesses
Table 185. MtoZ-Biolabs Basic Information, Manufacturing Base and Competitors
Table 186. MtoZ-Biolabs Major Business
Table 187. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Services
Table 188. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MtoZ-Biolabs Recent Developments/Updates
Table 190. MtoZ-Biolabs Competitive Strengths & Weaknesses
Table 191. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 192. Creative Proteomics Major Business
Table 193. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 194. Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Creative Proteomics Recent Developments/Updates
Table 196. Creative Proteomics Competitive Strengths & Weaknesses
Table 197. Macrogen Basic Information, Manufacturing Base and Competitors
Table 198. Macrogen Major Business
Table 199. Macrogen Plasma and Serum Proteomics Analysis Service Product and Services
Table 200. Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Macrogen Recent Developments/Updates
Table 202. Macrogen Competitive Strengths & Weaknesses
Table 203. TATAA Biocenter Basic Information, Manufacturing Base and Competitors
Table 204. TATAA Biocenter Major Business
Table 205. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Services
Table 206. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. TATAA Biocenter Recent Developments/Updates
Table 208. TATAA Biocenter Competitive Strengths & Weaknesses
Table 209. OmicScouts (Momentum Biotechnologies) Basic Information, Manufacturing Base and Competitors
Table 210. OmicScouts (Momentum Biotechnologies) Major Business
Table 211. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Services
Table 212. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
Table 214. OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
Table 215. Precision Biomarker Laboratories (PBL) Basic Information, Manufacturing Base and Competitors
Table 216. Precision Biomarker Laboratories (PBL) Major Business
Table 217. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Services
Table 218. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Precision Biomarker Laboratories (PBL) Recent Developments/Updates
Table 220. Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
Table 221. Shanghai OE Biotech Basic Information, Manufacturing Base and Competitors
Table 222. Shanghai OE Biotech Major Business
Table 223. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Services
Table 224. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Shanghai OE Biotech Recent Developments/Updates
Table 226. Shanghai OE Biotech Competitive Strengths & Weaknesses
Table 227. RxCelerate Basic Information, Manufacturing Base and Competitors
Table 228. RxCelerate Major Business
Table 229. RxCelerate Plasma and Serum Proteomics Analysis Service Product and Services
Table 230. RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. RxCelerate Recent Developments/Updates
Table 232. RxCelerate Competitive Strengths & Weaknesses
Table 233. Proteomics International Basic Information, Manufacturing Base and Competitors
Table 234. Proteomics International Major Business
Table 235. Proteomics International Plasma and Serum Proteomics Analysis Service Product and Services
Table 236. Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Proteomics International Recent Developments/Updates
Table 238. Proteomics International Competitive Strengths & Weaknesses
Table 239. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 240. Proteome Sciences Major Business
Table 241. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Services
Table 242. Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Proteome Sciences Recent Developments/Updates
Table 244. Proteome Sciences Competitive Strengths & Weaknesses
Table 245. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 246. Westlake Omics Major Business
Table 247. Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Services
Table 248. Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Westlake Omics Recent Developments/Updates
Table 250. Westlake Omics Competitive Strengths & Weaknesses
Table 251. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 252. Crown Bioscience Major Business
Table 253. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Services
Table 254. Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Crown Bioscience Recent Developments/Updates
Table 256. Crown Bioscience Competitive Strengths & Weaknesses
Table 257. VProteomics Basic Information, Manufacturing Base and Competitors
Table 258. VProteomics Major Business
Table 259. VProteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 260. VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. VProteomics Recent Developments/Updates
Table 262. VProteomics Competitive Strengths & Weaknesses
Table 263. Shanghai Majorbio Bio-Pharm Basic Information, Manufacturing Base and Competitors
Table 264. Shanghai Majorbio Bio-Pharm Major Business
Table 265. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Services
Table 266. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Shanghai Majorbio Bio-Pharm Recent Developments/Updates
Table 268. Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
Table 269. Applied Biomics Basic Information, Manufacturing Base and Competitors
Table 270. Applied Biomics Major Business
Table 271. Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 272. Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Applied Biomics Recent Developments/Updates
Table 274. Applied Biomics Competitive Strengths & Weaknesses
Table 275. Sapient Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 276. Sapient Bioanalytics Major Business
Table 277. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Services
Table 278. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. Sapient Bioanalytics Recent Developments/Updates
Table 280. Sapient Bioanalytics Competitive Strengths & Weaknesses
Table 281. Global Key Players of Plasma and Serum Proteomics Analysis Service Upstream (Raw Materials)
Table 282. Global Plasma and Serum Proteomics Analysis Service Typical Customers
Table 1. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Plasma and Serum Proteomics Analysis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Plasma and Serum Proteomics Analysis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Plasma and Serum Proteomics Analysis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Plasma and Serum Proteomics Analysis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Plasma and Serum Proteomics Analysis Service Players in 2025
Table 12. World Plasma and Serum Proteomics Analysis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Plasma and Serum Proteomics Analysis Service Company Evaluation Quadrant
Table 14. Head Office of Key Plasma and Serum Proteomics Analysis Service Players
Table 15. Plasma and Serum Proteomics Analysis Service Market: Company Product Type Footprint
Table 16. Plasma and Serum Proteomics Analysis Service Market: Company Product Application Footprint
Table 17. Plasma and Serum Proteomics Analysis Service Mergers & Acquisitions Activity
Table 18. United States VS China Plasma and Serum Proteomics Analysis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Plasma and Serum Proteomics Analysis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 23. China Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Plasma and Serum Proteomics Analysis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Plasma and Serum Proteomics Analysis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Plasma and Serum Proteomics Analysis Service Revenue Market Share (2021-2026)
Table 29. World Plasma and Serum Proteomics Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Plasma and Serum Proteomics Analysis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Plasma and Serum Proteomics Analysis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Plasma and Serum Proteomics Analysis Service Market Size by End User, (USD Million), 2021 & 2025 & 2032
Table 33. World Plasma and Serum Proteomics Analysis Service Market Size Value by End User (2021-2026) & (USD Million)
Table 34. World Plasma and Serum Proteomics Analysis Service Market Size by End User (2027-2032) & (USD Million)
Table 35. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Table 36. World Plasma and Serum Proteomics Analysis Service Market Size Value by Research Areas (2021-2026) & (USD Million)
Table 37. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas (2027-2032) & (USD Million)
Table 38. World Plasma and Serum Proteomics Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Plasma and Serum Proteomics Analysis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Plasma and Serum Proteomics Analysis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Olink (Thermo Fisher Scientific) Basic Information, Manufacturing Base and Competitors
Table 42. Olink (Thermo Fisher Scientific) Major Business
Table 43. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Product and Services
Table 44. Olink (Thermo Fisher Scientific) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Olink (Thermo Fisher Scientific) Recent Developments/Updates
Table 46. Olink (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 47. SomaLogic (Illumina) Basic Information, Manufacturing Base and Competitors
Table 48. SomaLogic (Illumina) Major Business
Table 49. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Product and Services
Table 50. SomaLogic (Illumina) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SomaLogic (Illumina) Recent Developments/Updates
Table 52. SomaLogic (Illumina) Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Plasma and Serum Proteomics Analysis Service Product and Services
Table 56. Labcorp Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. BostonGene Basic Information, Manufacturing Base and Competitors
Table 60. BostonGene Major Business
Table 61. BostonGene Plasma and Serum Proteomics Analysis Service Product and Services
Table 62. BostonGene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. BostonGene Recent Developments/Updates
Table 64. BostonGene Competitive Strengths & Weaknesses
Table 65. CellCarta Basic Information, Manufacturing Base and Competitors
Table 66. CellCarta Major Business
Table 67. CellCarta Plasma and Serum Proteomics Analysis Service Product and Services
Table 68. CellCarta Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. CellCarta Recent Developments/Updates
Table 70. CellCarta Competitive Strengths & Weaknesses
Table 71. GENEWIZ (Azenta Life Sciences) Basic Information, Manufacturing Base and Competitors
Table 72. GENEWIZ (Azenta Life Sciences) Major Business
Table 73. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Product and Services
Table 74. GENEWIZ (Azenta Life Sciences) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GENEWIZ (Azenta Life Sciences) Recent Developments/Updates
Table 76. GENEWIZ (Azenta Life Sciences) Competitive Strengths & Weaknesses
Table 77. CDI Labs Basic Information, Manufacturing Base and Competitors
Table 78. CDI Labs Major Business
Table 79. CDI Labs Plasma and Serum Proteomics Analysis Service Product and Services
Table 80. CDI Labs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CDI Labs Recent Developments/Updates
Table 82. CDI Labs Competitive Strengths & Weaknesses
Table 83. Biognosys Basic Information, Manufacturing Base and Competitors
Table 84. Biognosys Major Business
Table 85. Biognosys Plasma and Serum Proteomics Analysis Service Product and Services
Table 86. Biognosys Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Biognosys Recent Developments/Updates
Table 88. Biognosys Competitive Strengths & Weaknesses
Table 89. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 90. Discovery Life Sciences Major Business
Table 91. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Product and Services
Table 92. Discovery Life Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Discovery Life Sciences Recent Developments/Updates
Table 94. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 95. Firalis Molecular Precision Basic Information, Manufacturing Base and Competitors
Table 96. Firalis Molecular Precision Major Business
Table 97. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Product and Services
Table 98. Firalis Molecular Precision Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Firalis Molecular Precision Recent Developments/Updates
Table 100. Firalis Molecular Precision Competitive Strengths & Weaknesses
Table 101. Cell Signaling Technology (CST) Basic Information, Manufacturing Base and Competitors
Table 102. Cell Signaling Technology (CST) Major Business
Table 103. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Product and Services
Table 104. Cell Signaling Technology (CST) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Cell Signaling Technology (CST) Recent Developments/Updates
Table 106. Cell Signaling Technology (CST) Competitive Strengths & Weaknesses
Table 107. Sampled (Infinity Biologix) Basic Information, Manufacturing Base and Competitors
Table 108. Sampled (Infinity Biologix) Major Business
Table 109. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Product and Services
Table 110. Sampled (Infinity Biologix) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sampled (Infinity Biologix) Recent Developments/Updates
Table 112. Sampled (Infinity Biologix) Competitive Strengths & Weaknesses
Table 113. APTBIO Basic Information, Manufacturing Base and Competitors
Table 114. APTBIO Major Business
Table 115. APTBIO Plasma and Serum Proteomics Analysis Service Product and Services
Table 116. APTBIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. APTBIO Recent Developments/Updates
Table 118. APTBIO Competitive Strengths & Weaknesses
Table 119. Sinotech Genomics Basic Information, Manufacturing Base and Competitors
Table 120. Sinotech Genomics Major Business
Table 121. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 122. Sinotech Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sinotech Genomics Recent Developments/Updates
Table 124. Sinotech Genomics Competitive Strengths & Weaknesses
Table 125. Biodesix Basic Information, Manufacturing Base and Competitors
Table 126. Biodesix Major Business
Table 127. Biodesix Plasma and Serum Proteomics Analysis Service Product and Services
Table 128. Biodesix Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Biodesix Recent Developments/Updates
Table 130. Biodesix Competitive Strengths & Weaknesses
Table 131. Panome Bio Basic Information, Manufacturing Base and Competitors
Table 132. Panome Bio Major Business
Table 133. Panome Bio Plasma and Serum Proteomics Analysis Service Product and Services
Table 134. Panome Bio Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Panome Bio Recent Developments/Updates
Table 136. Panome Bio Competitive Strengths & Weaknesses
Table 137. Novogene Basic Information, Manufacturing Base and Competitors
Table 138. Novogene Major Business
Table 139. Novogene Plasma and Serum Proteomics Analysis Service Product and Services
Table 140. Novogene Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Novogene Recent Developments/Updates
Table 142. Novogene Competitive Strengths & Weaknesses
Table 143. PTM BIO Basic Information, Manufacturing Base and Competitors
Table 144. PTM BIO Major Business
Table 145. PTM BIO Plasma and Serum Proteomics Analysis Service Product and Services
Table 146. PTM BIO Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. PTM BIO Recent Developments/Updates
Table 148. PTM BIO Competitive Strengths & Weaknesses
Table 149. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 150. BGI Genomics Major Business
Table 151. BGI Genomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 152. BGI Genomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. BGI Genomics Recent Developments/Updates
Table 154. BGI Genomics Competitive Strengths & Weaknesses
Table 155. Evotec Basic Information, Manufacturing Base and Competitors
Table 156. Evotec Major Business
Table 157. Evotec Plasma and Serum Proteomics Analysis Service Product and Services
Table 158. Evotec Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Evotec Recent Developments/Updates
Table 160. Evotec Competitive Strengths & Weaknesses
Table 161. Metware Biotechnology Basic Information, Manufacturing Base and Competitors
Table 162. Metware Biotechnology Major Business
Table 163. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Product and Services
Table 164. Metware Biotechnology Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Metware Biotechnology Recent Developments/Updates
Table 166. Metware Biotechnology Competitive Strengths & Weaknesses
Table 167. MRM Proteomics Basic Information, Manufacturing Base and Competitors
Table 168. MRM Proteomics Major Business
Table 169. MRM Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 170. MRM Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. MRM Proteomics Recent Developments/Updates
Table 172. MRM Proteomics Competitive Strengths & Weaknesses
Table 173. Lc-Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 174. Lc-Bio Technologies Major Business
Table 175. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Product and Services
Table 176. Lc-Bio Technologies Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lc-Bio Technologies Recent Developments/Updates
Table 178. Lc-Bio Technologies Competitive Strengths & Weaknesses
Table 179. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 180. Eurofins Scientific Major Business
Table 181. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Product and Services
Table 182. Eurofins Scientific Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Eurofins Scientific Recent Developments/Updates
Table 184. Eurofins Scientific Competitive Strengths & Weaknesses
Table 185. MtoZ-Biolabs Basic Information, Manufacturing Base and Competitors
Table 186. MtoZ-Biolabs Major Business
Table 187. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Product and Services
Table 188. MtoZ-Biolabs Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. MtoZ-Biolabs Recent Developments/Updates
Table 190. MtoZ-Biolabs Competitive Strengths & Weaknesses
Table 191. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 192. Creative Proteomics Major Business
Table 193. Creative Proteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 194. Creative Proteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. Creative Proteomics Recent Developments/Updates
Table 196. Creative Proteomics Competitive Strengths & Weaknesses
Table 197. Macrogen Basic Information, Manufacturing Base and Competitors
Table 198. Macrogen Major Business
Table 199. Macrogen Plasma and Serum Proteomics Analysis Service Product and Services
Table 200. Macrogen Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Macrogen Recent Developments/Updates
Table 202. Macrogen Competitive Strengths & Weaknesses
Table 203. TATAA Biocenter Basic Information, Manufacturing Base and Competitors
Table 204. TATAA Biocenter Major Business
Table 205. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Product and Services
Table 206. TATAA Biocenter Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. TATAA Biocenter Recent Developments/Updates
Table 208. TATAA Biocenter Competitive Strengths & Weaknesses
Table 209. OmicScouts (Momentum Biotechnologies) Basic Information, Manufacturing Base and Competitors
Table 210. OmicScouts (Momentum Biotechnologies) Major Business
Table 211. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Product and Services
Table 212. OmicScouts (Momentum Biotechnologies) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. OmicScouts (Momentum Biotechnologies) Recent Developments/Updates
Table 214. OmicScouts (Momentum Biotechnologies) Competitive Strengths & Weaknesses
Table 215. Precision Biomarker Laboratories (PBL) Basic Information, Manufacturing Base and Competitors
Table 216. Precision Biomarker Laboratories (PBL) Major Business
Table 217. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Product and Services
Table 218. Precision Biomarker Laboratories (PBL) Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Precision Biomarker Laboratories (PBL) Recent Developments/Updates
Table 220. Precision Biomarker Laboratories (PBL) Competitive Strengths & Weaknesses
Table 221. Shanghai OE Biotech Basic Information, Manufacturing Base and Competitors
Table 222. Shanghai OE Biotech Major Business
Table 223. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Product and Services
Table 224. Shanghai OE Biotech Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Shanghai OE Biotech Recent Developments/Updates
Table 226. Shanghai OE Biotech Competitive Strengths & Weaknesses
Table 227. RxCelerate Basic Information, Manufacturing Base and Competitors
Table 228. RxCelerate Major Business
Table 229. RxCelerate Plasma and Serum Proteomics Analysis Service Product and Services
Table 230. RxCelerate Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. RxCelerate Recent Developments/Updates
Table 232. RxCelerate Competitive Strengths & Weaknesses
Table 233. Proteomics International Basic Information, Manufacturing Base and Competitors
Table 234. Proteomics International Major Business
Table 235. Proteomics International Plasma and Serum Proteomics Analysis Service Product and Services
Table 236. Proteomics International Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Proteomics International Recent Developments/Updates
Table 238. Proteomics International Competitive Strengths & Weaknesses
Table 239. Proteome Sciences Basic Information, Manufacturing Base and Competitors
Table 240. Proteome Sciences Major Business
Table 241. Proteome Sciences Plasma and Serum Proteomics Analysis Service Product and Services
Table 242. Proteome Sciences Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Proteome Sciences Recent Developments/Updates
Table 244. Proteome Sciences Competitive Strengths & Weaknesses
Table 245. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 246. Westlake Omics Major Business
Table 247. Westlake Omics Plasma and Serum Proteomics Analysis Service Product and Services
Table 248. Westlake Omics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Westlake Omics Recent Developments/Updates
Table 250. Westlake Omics Competitive Strengths & Weaknesses
Table 251. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 252. Crown Bioscience Major Business
Table 253. Crown Bioscience Plasma and Serum Proteomics Analysis Service Product and Services
Table 254. Crown Bioscience Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Crown Bioscience Recent Developments/Updates
Table 256. Crown Bioscience Competitive Strengths & Weaknesses
Table 257. VProteomics Basic Information, Manufacturing Base and Competitors
Table 258. VProteomics Major Business
Table 259. VProteomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 260. VProteomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. VProteomics Recent Developments/Updates
Table 262. VProteomics Competitive Strengths & Weaknesses
Table 263. Shanghai Majorbio Bio-Pharm Basic Information, Manufacturing Base and Competitors
Table 264. Shanghai Majorbio Bio-Pharm Major Business
Table 265. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Product and Services
Table 266. Shanghai Majorbio Bio-Pharm Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Shanghai Majorbio Bio-Pharm Recent Developments/Updates
Table 268. Shanghai Majorbio Bio-Pharm Competitive Strengths & Weaknesses
Table 269. Applied Biomics Basic Information, Manufacturing Base and Competitors
Table 270. Applied Biomics Major Business
Table 271. Applied Biomics Plasma and Serum Proteomics Analysis Service Product and Services
Table 272. Applied Biomics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Applied Biomics Recent Developments/Updates
Table 274. Applied Biomics Competitive Strengths & Weaknesses
Table 275. Sapient Bioanalytics Basic Information, Manufacturing Base and Competitors
Table 276. Sapient Bioanalytics Major Business
Table 277. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Product and Services
Table 278. Sapient Bioanalytics Plasma and Serum Proteomics Analysis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 279. Sapient Bioanalytics Recent Developments/Updates
Table 280. Sapient Bioanalytics Competitive Strengths & Weaknesses
Table 281. Global Key Players of Plasma and Serum Proteomics Analysis Service Upstream (Raw Materials)
Table 282. Global Plasma and Serum Proteomics Analysis Service Typical Customers
LIST OF FIGURES
Figure 1. Plasma and Serum Proteomics Analysis Service Picture
Figure 2. World Plasma and Serum Proteomics Analysis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Plasma and Serum Proteomics Analysis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 13. Plasma and Serum Proteomics Analysis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Plasma and Serum Proteomics Analysis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Plasma and Serum Proteomics Analysis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Plasma and Serum Proteomics Analysis Service Markets in 2025
Figure 27. United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Plasma and Serum Proteomics Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type in 2025
Figure 31. Plasma Proteomics Analysis Service
Figure 32. Serum Proteomics Analysis Service
Figure 33. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type (2021-2032)
Figure 34. World Plasma and Serum Proteomics Analysis Service Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 35. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User in 2025
Figure 36. Universities and Research Institutes
Figure 37. Hospitals
Figure 38. Pharmaceutical Companies
Figure 39. Others
Figure 40. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User (2021-2032)
Figure 41. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 42. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas in 2025
Figure 43. Oncology
Figure 44. Cardiovascular
Figure 45. Agriculture
Figure 46. Neuroscience
Figure 47. Other
Figure 48. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas (2021-2032)
Figure 49. World Plasma and Serum Proteomics Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application in 2025
Figure 51. Disease Biomarker Research
Figure 52. Drug Development
Figure 53. Clinical Research
Figure 54. Others
Figure 55. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application (2021-2032)
Figure 56. Plasma and Serum Proteomics Analysis Service Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Plasma and Serum Proteomics Analysis Service Picture
Figure 2. World Plasma and Serum Proteomics Analysis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Plasma and Serum Proteomics Analysis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Plasma and Serum Proteomics Analysis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Plasma and Serum Proteomics Analysis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Plasma and Serum Proteomics Analysis Service Revenue (2021-2032) & (USD Million)
Figure 13. Plasma and Serum Proteomics Analysis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Plasma and Serum Proteomics Analysis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Plasma and Serum Proteomics Analysis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Plasma and Serum Proteomics Analysis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Plasma and Serum Proteomics Analysis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Plasma and Serum Proteomics Analysis Service Markets in 2025
Figure 27. United States VS China: Plasma and Serum Proteomics Analysis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Plasma and Serum Proteomics Analysis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Plasma and Serum Proteomics Analysis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type in 2025
Figure 31. Plasma Proteomics Analysis Service
Figure 32. Serum Proteomics Analysis Service
Figure 33. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Type (2021-2032)
Figure 34. World Plasma and Serum Proteomics Analysis Service Market Size by End User, (USD Million), 2021 & 2025 & 2032
Figure 35. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User in 2025
Figure 36. Universities and Research Institutes
Figure 37. Hospitals
Figure 38. Pharmaceutical Companies
Figure 39. Others
Figure 40. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by End User (2021-2032)
Figure 41. World Plasma and Serum Proteomics Analysis Service Market Size by Research Areas, (USD Million), 2021 & 2025 & 2032
Figure 42. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas in 2025
Figure 43. Oncology
Figure 44. Cardiovascular
Figure 45. Agriculture
Figure 46. Neuroscience
Figure 47. Other
Figure 48. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Research Areas (2021-2032)
Figure 49. World Plasma and Serum Proteomics Analysis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application in 2025
Figure 51. Disease Biomarker Research
Figure 52. Drug Development
Figure 53. Clinical Research
Figure 54. Others
Figure 55. World Plasma and Serum Proteomics Analysis Service Market Size Market Share by Application (2021-2032)
Figure 56. Plasma and Serum Proteomics Analysis Service Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source
